| |
| |
|
| Insider
Information: |
Lewis Joel |
| Relationship: |
|
| City: |
Norcross |
| State: |
GA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
897,012 |
|
|
Indirect Shares
|
2,000 |
|
|
| Direct
Value |
$2,735,887 |
|
|
|
Indirect Value
|
$6,100 |
|
|
| Total
Shares |
899,012 |
|
|
| Total
Value |
$2,741,987 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 13.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Galectin Therapeutics Inc |
GALT |
|
2024-04-24 |
897,012 |
2024-04-24 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-12-15 |
4 |
A |
$1.16 |
$17,500 |
D/D |
15,086 |
683,380 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-12-30 |
4 |
A |
$1.13 |
$17,500 |
D/D |
15,487 |
698,867 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-01-13 |
4 |
A |
$1.14 |
$17,500 |
D/D |
15,351 |
714,218 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-01-31 |
4 |
A |
$1.16 |
$17,500 |
D/D |
15,086 |
729,304 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-03-31 |
4 |
A |
$1.61 |
$17,501 |
D/D |
10,870 |
458,870 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-08-15 |
4 |
A |
$2.18 |
$17,501 |
D/D |
8,028 |
587,194 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-08-31 |
4 |
A |
$1.90 |
$17,501 |
D/D |
9,211 |
596,405 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-09-15 |
4 |
A |
$1.79 |
$17,501 |
D/D |
9,777 |
606,182 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-11-30 |
4 |
A |
$1.27 |
$17,501 |
D/D |
13,780 |
668,294 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-06-15 |
4 |
A |
$1.29 |
$17,776 |
D/D |
13,780 |
520,431 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2020-02-09 |
4 |
OE |
$2.39 |
$19,120 |
D/D |
8,000 |
107,104 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2022-09-30 |
4 |
A |
$1.79 |
$19,217 |
D/D |
10,736 |
616,918 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-03-15 |
4 |
A |
$1.90 |
$19,266 |
D/D |
10,140 |
830,439 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-04-14 |
4 |
A |
$2.01 |
$19,266 |
D/D |
9,585 |
849,199 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-06-15 |
4 |
A |
$1.46 |
$19,266 |
D/D |
13,196 |
897,362 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-07-31 |
4 |
A |
$1.50 |
$19,266 |
D/D |
12,844 |
935,406 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-10-13 |
4/A |
A |
$2.01 |
$19,266 |
D/D |
9,585 |
989,025 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-10-31 |
4 |
A |
$2.04 |
$19,266 |
D/D |
9,444 |
998,469 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-11-30 |
4 |
A |
$1.95 |
$19,266 |
D/D |
9,880 |
1,018,652 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-12-29 |
4 |
A |
$1.66 |
$19,266 |
D/D |
11,606 |
1,042,300 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-02-15 |
4 |
A |
$1.44 |
$19,267 |
D/D |
13,380 |
886,520 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-04-28 |
4 |
A |
$1.76 |
$19,267 |
D/D |
10,947 |
860,146 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-05-15 |
4 |
A |
$1.64 |
$19,267 |
D/D |
11,748 |
871,894 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-05-31 |
4 |
A |
$1.57 |
$19,267 |
D/D |
12,272 |
884,166 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
President and CEO |
• • – |
2023-06-30 |
4 |
A |
$1.44 |
$19,267 |
D/D |
13,380 |
911 |
0 |
- |
|
93 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
